The New York Times editorial board laid out five questions the Senate Finance Committee should ask the seven pharmaceutical companies testifying at a hearing Feb. 26. 1. How are list prices determined ...

For people who rely on certain prescription drugs, including weight loss, asthma and cancer medications, President Donald Trump’s post announcing 100% tariffs on foreign brand-name drugs offers little ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Enabling patients to order prescription medications directly from ...

Shares of global pharmaceutical companies opened lower Tuesday, after President Donald Trump signed a highly-anticipated executive order aimed at lowering drug prices for Americans. The order was “not ...

While cancer treatment is progressing at a fast rate the world over with new targeted drugs being launched, immunotherapy and radiation, therapy resistance continues to remain an obstacle in the road ...

New deals between big pharma and academic institutions raise questions about IP ownership and patent strategies. Zöe Clyde-Watson examines how to avoid entitlement disputes Pharmaceutical companies, ...

Exclusive interviews revealed that digital transformation, data integrity protocols, and a regionalized supply chain are crucial strategies for optimizing drug development and manufacturing efficiency ...

A much-anticipated February 20 meeting between President Donald Trump and representatives of the pharmaceutical industry ended without the companies getting a firm commitment from the new ...

For people who rely on certain prescription drugs, including weight loss, asthma and cancer medications, President Donald Trump’s post announcing 100% tariffs on foreign brand-name drugs offers little ...